BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36180599)

  • 1. Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma.
    Della Corte A; Sallemi C; Ratti F; Monfardini L; Gusmini S; Cipriani F; Pennella R; Santangelo D; Burgio V; Casadei-Gardini A; Aldrighetti L; De Cobelli F
    Cardiovasc Intervent Radiol; 2023 Jan; 46(1):49-59. PubMed ID: 36180599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
    Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.
    Chen G; Chen H; Huang X; Cheng S; Zheng S; Wu Y; Zheng T; Chen X; Guo X; Zhang Z; Xie X; Zhang B
    Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 36013483
    [No Abstract]   [Full Text] [Related]  

  • 7. Different power modes of microwave ablation for hepatocellular carcinoma: Evaluation of recurrence rate and factors related to recurrence.
    Dong T; Nie F; Liu T; Wang L; Yang D; Yan X
    Asian J Surg; 2023 Sep; 46(9):3520-3528. PubMed ID: 37002048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
    Liu K; Zheng H; Sui X; Liu B; Meng M; Feng Y; Zhu Q; Zhao X
    Eur Radiol; 2023 Mar; 33(3):1938-1948. PubMed ID: 36114849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study.
    Chiang J; Rajendran PS; Hao F; Sayre J; Raman SS; Lu DSK; McWilliams JP
    Diagn Interv Radiol; 2023 Nov; 29(6):805-812. PubMed ID: 37665139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation.
    Chen TM; Lin CC; Huang PT; Wen CF
    J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases.
    Liu C; He J; Li T; Hong D; Su H; Shao H
    Abdom Radiol (NY); 2021 May; 46(5):2161-2172. PubMed ID: 33108496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous US-guided MWA of small liver HCC: predictors of outcome and risk factors for complications from a single center experience.
    Biondetti P; Fumarola EM; Ierardi AM; Coppola A; Gorga G; Maggi L; Valconi E; Angileri SA; Carrafiello G
    Med Oncol; 2020 Apr; 37(5):39. PubMed ID: 32239295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of microwave ablation on platelet and coagulation function in patients with BCLC-A hepatocellular carcinoma.
    Zhao W; Li H; Li W; Guo J; Cai L; Duan Y; Hou X; Diao Z; Shao X; Du H; Li W; Li C
    J Cancer Res Ther; 2021 Nov; 17(5):1275-1280. PubMed ID: 34850778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
    Hu H; Chi JC; Liu R; Zhai B
    Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.
    Zhang NN; Lu W; Cheng XJ; Liu JY; Zhou YH; Li F
    Clin Radiol; 2015 Nov; 70(11):1237-43. PubMed ID: 26220125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of percutaneous microwave ablation for hepatocellular carcinomas <4 cm in difficult location.
    Mukund A; Ramalingam R; Anandpara KM; Patidar Y; Vijayaraghavan R; Sarin SK
    Br J Radiol; 2020 Dec; 93(1116):20191025. PubMed ID: 32970472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.